Search

Search Constraints

You searched for: Author/Creator Fellous, Marc

Search Results

3. Association of FOXD1 variants with adverse pregnancy outcomes in mice and humans. Issue 10 (October 2016)

4. CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET. (9th November 2020)

5. HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours. (3rd June 2022)

6. Impact of Disease Evolution on Efficacy Outcomes From Larotrectinib in Patients With Locally Advanced or Metastatic Tropomyosin Receptor Kinase Fusion–Positive Solid Tumors. (2021)

8. Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100, 000 genomes project. (2022)